RT @beth_morton: Trying to get your doctor or insurance to consider (approve) a higher #Emgality dose for #migraine? This study might help:…
2,076 followers
194 followers
片頭痛に対するCGRPモノクローナル抗体eptinezumabの有効性(4RCTより、2,739例)。Eptinezumab(30mg/100mg/300mg)はプラセボと比較し、12週目の平均月間片頭痛日数の有意な減少。とくに300mgでその効果は高い。また有害事象の増加もなし。 #540 https://t.co/cRgr4YNcVh
151 followers
RT @EHF_Official: A meta-analysis to systematically evaluate the efficacy and safety of eptinezumab for the treatment of migraine compared…
2,192 followers
RT @beth_morton: Trying to get your doctor or insurance to consider (approve) a higher #Emgality dose for #migraine? This study might help:…